Company Filing History:
Years Active: 2011-2013
Title: Innovator Spotlight: Keith S. Rotenberg
Introduction
Keith S. Rotenberg is an accomplished inventor based in Denville, NJ, United States. With a focus on pharmaceutical innovations, he has been recognized for his contributions to the development of advanced drug formulations. His inventions primarily center around fenofibrate, a medication commonly used to treat high cholesterol and triglyceride levels.
Latest Patents
Keith holds two notable patents that exemplify his innovative approach in pharmaceutical composition. The first patent involves a pharmaceutical composition containing fenofibrate, enhanced through the use of micronization, surfactants, and binding cellulose derivatives to improve solubility. The second patent closely mirrors this theme, detailing methods for producing fenofibrate compositions that contain a substantial amount of the active ingredient, specifically 60% by weight or more, ensuring effective delivery and bioavailability of the drug.
Career Highlights
Currently, Keith is associated with Ethypharm, Inc., a company known for its dedication to the development of innovative pharmaceutical solutions. His role at Ethypharm has positioned him at the forefront of research and development, enabling him to bring impactful therapeutic products to market.
Collaborations
Throughout his career, Keith has collaborated with seasoned professionals Bruno Criere and Pascal Suplie. These partnerships showcase the importance of teamwork in advancing pharmaceutical research and the shared goal of innovation in medicine.
Conclusion
Keith S. Rotenberg stands out as a significant contributor to the field of pharmaceuticals, with a focus on improving drug formulations through innovation. His work continues to impact the health industry, aiding in the treatment of conditions associated with high cholesterol and triglyceride levels.